EU Drug Regulator Recommends Clearing Bavarian Nordic Vaccine for Monkeypox

EU Drug Regulator Recommends Clearing Bavarian Nordic Vaccine for Monkeypox
Test tubes labeled "Monkeypox virus positive and negative" are seen in this illustration taken on May 23, 2022. Dado Ruvic/Reuters
|Updated:

LONDON—The European Medicines Agency said Friday that the smallpox vaccine made by Bavarian Nordic should also be authorized against monkeypox.

The European Union drug regulator said its recommendation was based on animal studies that suggest the vaccine protects non-human primates from monkeypox. It is up to the EU’s executive arm, the European Commission, to formally approve the vaccine based on the EMA’s recommendation.